Selected article for: "chronic HCV infection and HCV patient"

Author: Rajasekaran, Arun; Franco, Ricardo A.; Overton, Edgar T.; McGuire, Brendan M.; Towns, Graham C.; Locke, Jayme E.; Sawinski, Deirdre L.; Bell, Emmy K.
Title: Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population
  • Cord-id: loqdjd7i
  • Document date: 2021_4_25
  • ID: loqdjd7i
    Snippet: Chronic hepatitis C virus (HCV) infection continues to be transmitted to hemodialysis (HD) patients within HD facilities globally. The goal of the World Health Organization to micro-eliminate HCV infection from the HD population by the year 2030 is not on target to be achieved. Obstacles to eliminate HCV in HD settings remain daunting due to a complex system created by a confluence of guidelines, legislation, regulation, and economics. HCV prevalence remains high and seroconversion continues amo
    Document: Chronic hepatitis C virus (HCV) infection continues to be transmitted to hemodialysis (HD) patients within HD facilities globally. The goal of the World Health Organization to micro-eliminate HCV infection from the HD population by the year 2030 is not on target to be achieved. Obstacles to eliminate HCV in HD settings remain daunting due to a complex system created by a confluence of guidelines, legislation, regulation, and economics. HCV prevalence remains high and seroconversion continues among the HD patient population globally as a result of the HD procedure. Preventive strategies that effectively prevent HCV transmission, treatment-as-prevention, and rapid referral to treatment balanced with kidney transplant candidacy should be added to the current universal precautions approach. A safer system must be designed before HCV transmission can be halted and eliminated from the HD population.

    Search related documents:
    Co phrase search for related documents
    • access care and active infection: 1, 2
    • access care and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • access care and acute stage: 1, 2
    • access care and adequate management: 1, 2, 3
    • access care and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • accurate early and acid amplification detect: 1
    • accurate early and acid testing: 1, 2
    • accurate early and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • accurate early and acute stage: 1
    • accurate early detection and acute infection: 1, 2, 3
    • acid testing and active infection: 1, 2, 3, 4
    • acid testing and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acid testing and liver disease: 1, 2, 3
    • acid testing and liver failure: 1, 2
    • acid testing and liver level: 1
    • active infection and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and acute stage: 1, 2
    • active infection and liver disease: 1, 2, 3, 4, 5
    • active infection and liver failure: 1, 2, 3, 4, 5